New Results
A traditional medicine, Respiratory Detox Shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the Influenza A virus in vitro
Brian Hetrick, Dongyang Yu, Adeyemi A. Olanrewaju, Linda D. Chilin, Sijia He, Deemah Debbagh, Yuan-Chun Ma, Lewis A. Hofmann, Ramin M. Hakami, Yuntao Wu
doi: https://doi.org/10.1101/2020.12.10.420489
Brian Hetrick
1National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA 20110, USA
Dongyang Yu
2Virongy LLC, Manassas, VA 20109, USA
Adeyemi A. Olanrewaju
1National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA 20110, USA
Linda D. Chilin
1National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA 20110, USA
Sijia He
1National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA 20110, USA
Deemah Debbagh
1National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA 20110, USA
Yuan-Chun Ma
3Dr. Ma’s Laboratories Inc. Burnaby, BC V5J 0E5, Canada
Lewis A. Hofmann
4World Health Science Organization, Leesburg, VA 20176, USA
Ramin M. Hakami
1National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA 20110, USA
Yuntao Wu
1National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA 20110, USA
Article usage
Posted December 14, 2020.
A traditional medicine, Respiratory Detox Shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the Influenza A virus in vitro
Brian Hetrick, Dongyang Yu, Adeyemi A. Olanrewaju, Linda D. Chilin, Sijia He, Deemah Debbagh, Yuan-Chun Ma, Lewis A. Hofmann, Ramin M. Hakami, Yuntao Wu
bioRxiv 2020.12.10.420489; doi: https://doi.org/10.1101/2020.12.10.420489
A traditional medicine, Respiratory Detox Shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the Influenza A virus in vitro
Brian Hetrick, Dongyang Yu, Adeyemi A. Olanrewaju, Linda D. Chilin, Sijia He, Deemah Debbagh, Yuan-Chun Ma, Lewis A. Hofmann, Ramin M. Hakami, Yuntao Wu
bioRxiv 2020.12.10.420489; doi: https://doi.org/10.1101/2020.12.10.420489
Subject Area
Subject Areas
- Biochemistry (11739)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17409)
- Clinical Trials (138)
- Developmental Biology (9419)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12238)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28068)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)